Latest News & Features
Americas
A proposed amendment in Mexican law needs to be implemented urgently in order to adapt legislation to include provisions in accordance with the UPOV Convention, as Luz Flores of Uhthoff, Gómez Vega & Uhthoff reports. 10 October 2018
Americas
A former Johnson & Johnson IP counsel and a retired judge are among the speakers at Life Sciences IP Due Diligence, on November 29 and 30 in Boston, as LSIPR finds out. 10 October 2018
Americas
North Carolina-based Duke University and Allergan have brought their patent dispute with medical company Alcon Laboratories to an end in Delaware. 9 October 2018
Americas
The IP concessions in the United States-Mexico-Canada Agreement are the latest hit for access to affordable prescription medicines for Canadians, according to the Canadian Generic Pharmaceutical Association. 9 October 2018
Americas
The US International Trade Commission has voted to begin an investigation into US medical device maker ResMed following a complaint from New Zealand-based rival Fisher & Paykel Healthcare. 8 October 2018
Americas
US-based law firm O’Melveny has hired Hassen Sayeed as a partner in its IP and technology practice group in New York. 8 October 2018
Biotechnology
Depending on the facts and the content of the applications, an Arrow-type declaration could be made on grounds of insufficiency against divisional applications, say David Holt and Tony Proctor of Potter Clarkson. 8 October 2018
Americas
The Patent Trial and Appeal Board invalidated a patent owned by biotech company Biogen yesterday, handing a victory to South Korea-based Celltrion. 5 October 2018
Americas
Janssen, a subsidiary of Johnson & Johnson, has entered into a licence and collaboration agreement with drug maker Arrowhead Pharmaceuticals. 5 October 2018
Big Pharma
The UK’s Medicines and Healthcare Products Regulatory Agency is seeking industry views on a no-deal Brexit scenario. 4 October 2018